Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Archive for 27 dicembre 2019

MusashiAI Launches World’s First Robot Employment Agency

Posted by fidest press agency su venerdì, 27 dicembre 2019

MusashiAI, a joint venture between SixAI Ltd. of Israel and Musashi Seimitsu of Japan (a Honda Motor Corporation affiliate company), has launched its fully-autonomous robots to integrate seamlessly with human workers in an industry 4.0 factory environment. Its robots will undertake the often strenuous and repetitive work endured by humans in industrial workplaces.Both of its forklift and visual inspection AI-controlled robots are being tested by Musashi Seimitsu, a global leader in ​automotive transmission parts with 35 manufacturing plants worldwide.The JV also introduces a unique business model by providing industrial employers an option to source needed labour through a robotic employment agency, instead of investing significant capital in purchasing robots.The model allows companies to hire robot labor by the hour or pay a task-completed-based salary rate.These developments represent a major leap forward in the deployment of robots: The robots are genuinely autonomous, opposed to automated – they are given tasks and define their own optimal way to perform them, just as humans do. The new commercial model of hiring robots by the hour or task means that they are now available to support many more companies or organizations. An experienced human quality control inspector checks manufactured parts for defects in approximately 2 seconds per part with 97% accuracy. Traditionally, the better robots took over 20 seconds per component at 70% accuracy. MusashiAI’s robots work at a similar effectiveness to humans at 2 seconds with 98% accuracy.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

CDW Announces Board Transition

Posted by fidest press agency su venerdì, 27 dicembre 2019

CDW Corporation (Nasdaq: CDW), a leading multi-brand technology solutions provider to business, government, education and healthcare customers, today announced that David W. Nelms will become non-executive chairman of the board, effective January 1, 2020. He will succeed Thomas E. Richards, executive chairman, who will retire from the board as of December 31, 2019. This chairman succession is the culmination of a leadership transition that began several years ago. “David has been a valued board member for the past six years, and our entire board is pleased that he has accepted this additional leadership role and special responsibility to contribute to and serve CDW in this capacity,” said Christine A. Leahy, chief executive officer, CDW. “I look forward to working with David and our full board as CDW continues to execute our growth strategy.”
Leahy also recognized the special role that Tom Richards has had in CDW’s success: “I am proud and privileged, on behalf of our Board of Directors and more than 9,800 coworkers and all CDW stakeholders, to thank Tom for his decade of exceptional contribution and service. Tom reminded us daily of our opportunity and responsibility to ‘make a difference,’ and Tom most surely did so. His exceptional legacy will carry on in countless ways.” “I am honored to serve as the next chairman for a company with such a rich history and bright future,” Nelms said. “I want to personally thank Tom for the excellent stewardship he has provided as chairman and for his outstanding leadership over a decade of service to CDW.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Stoke Therapeutics Added to NASDAQ Biotechnology Index

Posted by fidest press agency su venerdì, 27 dicembre 2019

Stoke Therapeutics, Inc. (Nasdaq:STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:NBI). This addition is effective prior to market open today. The NASDAQ Biotechnology Index tracks the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. Selected companies must meet eligibility requirements, including minimum market capitalization, average daily trading volume and seasoning as a public company, among other criteria. The NASDAQ Biotechnology Index is re-ranked annually and forms the basis for a number of Exchange Traded Funds (ETFs), including the iShares NASDAQ Biotechnology ETF. For more information about the NASDAQ Biotechnology Index visit https://indexes.nasdaqomx.com/Index/Overview/NBI.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Kopin Corporation Names Experienced Executive Vice President of Operations

Posted by fidest press agency su venerdì, 27 dicembre 2019

Kopin Corporation (NASDAQ:KOPN), a leading developer of innovative wearable computing technologies and solutions, today announced that Eric Whitman has joined the Company in the newly created position of Vice President of Operations. In this role, Whitman will be responsible for increasing productivity and efficiency across the business, including logistics, manufacturing and procurement. Whitman will report to Kopin’s CEO, Dr. John Fan.Eric Whitman brings extensive experience gained from positions at several Aerospace, Defense and technology companies. He career started at Intel as a shift manager at Fab 17 in Hudson Massachusetts, and he moved on to Raytheon where he rose to Director of Operations, Integrated Defense Systems, where he managed manufacturing, engineering processing and strategy, with an emphasis on increasing efficiency and profitability. Most recently Whitman was COO at Web Industries where his primary focus was on establishing and executing an operational strategy to scale Web’s business systems in anticipation of rapid growth across eight manufacturing plants in the US and Europe. Previous experiences as a Division Leader at Draper, and VP of Operations at Bodycote strengthened key skills in manufacturing and engineering leadership, establishing continuous improvement cultures, and the optimization of business systems and technology. All of these positions benefited from Whitman’s experience as a Lieutenant Commander in the US Navy, where he logged over 1000 hours in the SH-60B Seahawk Helicopter. Whitman is a graduate of the US Naval Academy with a BS in Aerospace Engineering. He also holds an MS from the Massachusetts Institute of Technology in Engineering and Management.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Ship.com Emerges From Stealth Mode for the Holidays

Posted by fidest press agency su venerdì, 27 dicembre 2019

Ship.com, an early-stage technology startup aiming to transform the way people track and ship their packages, has emerged from stealth mode as the first app for tracking, shipping, and sharing your packages. Ship.com socializes peer-to-peer shipments just as Venmo streamlined and socialized peer-to-peer payments. Ship.com centralizes all retailer tracking and delivery notifications in one app and offers package shipping from the phone with no address information required.The startup provides users with an innovative app to centralize tracking and delivery notifications from all retailers including Amazon and Walmart; sharing delivery information with friends and family; and shipping using a phone, at home or work, with USPS, UPS or FedEx.As online retailing continues its exponential growth and more people are shipping packages to friends and family, complexity around managing tracking information and package theft creates more stress and problems for consumers. Ship.com aims to capture the fun of online purchases and extend it to a centralized post-sales customer experience that simplifies the package delivery and shipping process.Ship.com was developed by a team led by Founder and CEO Joseph DiSorbo, a serial entrepreneur focused on ecommerce and logistics. DiSorbo previously founded Webgistix Corporation, an ecommerce software and order fulfillment company for small online retailers to compete with large retailers like Amazon. Rakuten, the largest online retailer in Japan, acquired Webgistix in 2013.The answer, Ship.com believes, is a new kind of app—simple, fun, and social. Rather than relying on retailers to send tracking email updates or push notifications, Ship.com links to users’ Gmail shopping email (the account where emails with tracking numbers get buried) and puts that tracking information in one place regardless of the retailer or delivery company. This puts an end to the barrage of multiple apps, emails and texts from retailers (and family members) about package deliveries.Sharing of delivery notifications with friends and family (including those using the same Amazon Prime account) eliminates the need for phone calls, emails and texts to others about the status of a package (and real-time notifications shared with people at the delivery location helps combat Porch Pirates).Ship.com also makes shipping packages to family and friends simple and fun with a mobile app that is easy to use and has the addresses you need with ShipTags (like sending money with Venmo). Users manage their own addresses so @joe can send to @kyle. Ship.com allows users to print shipping labels, compares prices, and arranges pickup at home or office at cheaper rates. No more standing in line at the post office, UPS or FedEx store to ship packages.Ship.com stayed under the radar for a year while building its platform, before launching on Product Hunt on November 26th. Product Hunt, the online community for people who want to discover and discuss the latest mobile apps, web platforms, and tech products, is the perfect place for Ship.com to reach new users. Ship.com also incubated as part of the Fuel Accelerator for growth stage startups. Ship.com is for people who want to simplify their lives and make the things they buy and ship easy, fun and social. It’s an innovative app that will be a product-focused social network where people can see what their contacts are actually buying, then comment, share, review and easily purchase these same products and/or easily send gifts based on users’ purchase history.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

New Research Demonstrates Clinical Viability of Epitope Mapping Technology Platform for Food Allergy Diagnosis

Posted by fidest press agency su venerdì, 27 dicembre 2019

AllerGenis, a data-driven precision diagnostics company focused on food allergies, this week reported research results in Scientific Reports from Nature, in preparation for the clinical launch of its bead-based epitope mapping diagnostic platform. The study quantified and validated the performance of the platform against the widely used peptide microarray assays in clinical patient populations.
AllerGenis’ diagnostic platform analyzes the reactivity and binding of patients’ IgE antibodies to epitopes of allergenic proteins, enabling a molecular level of resolution not available in current food allergy diagnostics and revealing actionable data about food allergies — diagnostic and prognostic assessment, level of allergen sensitivity, patient suitability for immunotherapy, and allergy subtypes.“Previous literature has established epitope binding as a high-precision method to characterize food allergies,” said lead author Mayte Suárez-Fariñas, Ph.D., Senior Faculty in Population Health Science and Policy, and Genetics and Genomic Sciences, of the Icahn School of Medicine at Mount Sinai. “Other methods, such as peptide microarrays, tried to make use of epitope mapping. However, they were labor intensive, required large serum samples, and had a limited detection frequency. With advances in data science and high-throughput instrumentation, we are now able to take full advantage of epitope analyses.” The newly published study followed AllerGenis’ standard protocol, where the allergenic epitopes are coupled to beads before incubation with serum or plasma samples and secondary fluorophore antibodies. The fluorescence signals are quantified by a Luminex reader, which are then converted to epitope-binding values to be used for diagnosis.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

CurePSP Funds Mount Sinai’s Friedman Brain Institute Research Scholars Partnership in Honor of Karen Cook

Posted by fidest press agency su venerdì, 27 dicembre 2019

CurePSP, the nonprofit advocacy organization for prime of life neurodegenerative diseases, has provided a $50,000 grant to Mount Sinai Health System for the 2020 Karen Strauss Cook Research Scholar Award.The funds, made possible through the generosity of the Anna-Maria and Stephen Kellen Foundation, will support early-stage investigation into brain function and disease as part of Mount Sinai’s Friedman Brain Institute Research Scholars Partnership. The program is open to Mount Sinai faculty including early to mid-career investigators who seek to form new collaborations with colleagues in other disciplines and senior scientists who wish to undertake a project outside of their usual area of investigation. Projects are designed with the goal of generating the preliminary data needed to secure external funding from the National Institutes of Health (NIH) or other sources.Lawrence I. Golbe, MD, CurePSP’s Director of Scientific Affairs, said, “We are very pleased to be supporting this initiative. The Mount Sinai program fits well with our own Venture Grants program, which provides seed funding to early career investigators who want to test innovative ideas. With success, these projects may lead to larger sources of funding to expand the research.”
Karen Strauss Cook was a Wall Street pioneer who was the first woman hired as a trader in the equities division at Goldman Sachs & Co. in New York and the third female finance professional at the firm. Later, she served as Chief Investment Officer at Steinhardt Partners, New York. Karen passed away in 2013 at age 61 from the effects of corticobasal degeneration (CBD), a rare neurodegenerative disease that is a focus of CurePSP-funded research.David Kemp, President of CurePSP, said, “CurePSP is pleased to be honoring Karen’s memory in this meaningful way. Karen would have been very pleased to know that we are supporting Mount Sinai’s innovative research program.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »